Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum"
- PMID: 27799262
- DOI: 10.1161/CIRCULATIONAHA.116.024837
Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum"
Comment on
-
Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2 DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum.Circulation. 2016 Apr 12;133(15):1504-11; discussion 1511. doi: 10.1161/CIRCULATIONAHA.115.016715. Circulation. 2016. PMID: 27067085 No abstract available.
-
Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum".Circulation. 2016 Nov 1;134(18):e387-e388. doi: 10.1161/CIRCULATIONAHA.116.023650. Circulation. 2016. PMID: 27799260 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical